Can UK NHS research ethics committees effectively monitor publication and outcome reporting bias? Ethics in Biomedical Research

BMC Medical Ethics

Volumn 16, Issue 1, 2015, Pages

  Begum, Rasheda ^a   Kolstoe, Simon ^a  

^a UNIVERSITY OF PORTSMOUTH   (United Kingdom)

Author keywords

Ethics committees; Publication bias; Publication ethics; Reporting bias; Research ethics

Indexed keywords

BIBLIOMETRICS; DECISION MAKING; ETHICS; HUMAN; NATIONAL HEALTH SERVICE; PERSONNEL; PROFESSIONAL STANDARD; PUBLISHING; RESEARCH; RESEARCH ETHICS; STATISTICAL BIAS; TREATMENT OUTCOME; UNITED KINGDOM;

BIAS (EPIDEMIOLOGY); BIBLIOMETRICS; CHOICE BEHAVIOR; ETHICS COMMITTEES, RESEARCH; ETHICS, RESEARCH; HUMANS; PUBLISHING; RESEARCH; RESEARCH PERSONNEL; STATE MEDICINE; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 84937963494     PISSN: None     EISSN: 14726939     Source Type: Journal    
DOI: 10.1186/s12910-015-0042-8     Document Type: Article

References (22)

1. Song F, Parekh S, Hooper L, Loke YK, Ryder J, Sutton AJ, et al. Dissemination and publication of research findings: an updated review of related biases. Health Technol Asses. 2010;14(8):1.
2. Dwan K, Gamble C, Williamson PR, Kirkham JJ, Grp RB. Systematic Review of the Empirical Evidence of Study Publication Bias and Outcome Reporting Bias-An Updated Review. Plos One. 2013;3(8):1-31.
3. AllTrials Campaign. http://www.alltrials.net. Accessed 6th November 2014
4. Goldacre B: Bad pharma: how drug companies mislead doctors and harm patients, First American edition. edn; 2012.
5. Drug companies have a year to publish their data, or we'll do it for them http://theconversation.com/drug-companies-have-a-year-to-publish-their-data-or-well-do-it-for-them-15184. Accessed on 6th November 2014
6. Health Research Authority. http://www.hra.nhs.uk. Accessed on 6th November 2014.
7. The HRA interest in good research conduct. http://www.hra.nhs.uk/documents/2013/08/transparent-research-report.pdf. Accessed on 6th November 2014.
8. Health Research Authority Business Plan 2013-2014. http://www.hra.nhs.uk/documents/2013/09/hra-business-plan-2013-2014.pdf. Accessed on 6th November 2014.
9. MedCalc 13. http://www.medcalc.org/index.php. Accessed on 5th May 2015.
10. Egger M, Smith GD, Altman DG. Systematic Reviews in Healthcare. 2nd ed. London: BMJ Books; 2001.
11. Pearn J. Publication-an Ethical Imperative. Brit Med J. 1995;310(6990):1313-5.
12. Antes G, Chalmers I. Under-reporting of clinical trials is unethical. Lancet. 2003;361(9362):978-9.
13. World Medical A. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama. 2013;310(20):2191-4.
14. Hopewell S, Loudon K, Clarke MJ, Oxman AD, Dickersin K: Publication bias in clinical trials due to statistical significance or direction of trial results. Cochrane Db Syst Rev. 2009;(1):1-23.
15. Sune-Martin P, Montoro-Ronsano JB. Role of a research ethics committee in follow-up and publication of results. Lancet. 2003;361(9376):2245-6.
16. Turer AT, Mahaffey KW, Compton KL, Califf RM, Schulman KA. Publication or presentation of results from multicenter clinical trials: Evidence from an academic medical center. Am Heart J. 2007;153(4):674-80.
17. Stern JM, Simes RJ. Publication bias: evidence of delayed publication in a cohort study of clinical research projects. Brit Med J. 1997;315(7109):640-5.
18. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. Jama. 1992;267(3):374-8.
19. Bland JM, Altman DG. Statistics notes-The odds ratio. Brit Med J. 2000;320(7247):1468-8.
20. Bekelman JE, Li Y, Gross CP. Scope and impact of financial conflicts of interest in biomedical research-A systematic review. Jama-J Am Med Assoc. 2003;289(4):454-65.
21. Chan AW, Hrobjartsson A, Haahr MT, Gotzsche PC, Altman DG. Empirical evidence for selective reporting of outcomes in randomized trials-Comparison of Protocols to published articles. Jama-J Am Med Assoc. 2004;291(20):2457-65.
22. Vedula SS, Bero L, Scherer RW, Dickersin K. Outcome Reporting in Industry-Sponsored Trials of Gabapentin for Off-Label Use. New Engl J Med. 2009;361(20):1963-71.